# Cytek Biosciences

the Cytek Borealis, a new seven-laser spectral flow cytometry system unveiled in 2026, extends full-spectrum detection depth for high-parameter immunophenotyping panels.


Source: https://en.bioecon.ru/companies/cytek-biosciences/
Updated: 2026-08-15

- Country: United States
- Ticker: NASDAQ:CTKB

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | $44.1 million for the quarter ended March 31, 2026 | https://www.marketscreener.com/news/cytek-biosciences-quarterly-report-for-quarter-ending-march-31-2026-form-10-q-ce7f5bdadc8bfe24 |
| Production site | Fremont, California; Wuxi, China; Seattle, Washington; and Singapore | https://www.marketscreener.com/news/cytek-biosciences-quarterly-report-for-quarter-ending-march-31-2026-form-10-q-ce7f5bdadc8bfe24 |
| Regulatory approval | Northern Lights-CLC system received CE Marking (2020) and is registered in the European Union (2023) and China (Class II) | https://www.marketscreener.com/news/cytek-biosciences-quarterly-report-for-quarter-ending-march-31-2026-form-10-q-ce7f5bdadc8bfe24 |
| Revenue | $201.5 million for 2025 | https://www.bccresearch.com/company-index/profile/cytek-biosciences-inc |
| Headcount | 702 employees | https://www.bccresearch.com/company-index/profile/cytek-biosciences-inc |

Independent sources: bccresearch.com, marketscreener.com

## Technologies

- [Flow cytometers for bioproduction](https://en.bioecon.ru/technology/flow-cytometers-bioproduction/)